BridgeBio Pharma, Inc. Long-term assets (Other)

Long-term assets (Other) of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.


Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending September 30, 2022 was $18 Million (a -37.93% decrease compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) decreased by -41.94%
  • Annual Long-term assets (Other) for 2021 was $33 Million (a 38.01% increase from previous year)
  • Annual Long-term assets (Other) for 2020 was $23.9 Million (a -8.97% decrease from previous year)
  • Annual Long-term assets (Other) for 2019 was $26.3 Million (a 2305.12% increase from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of BridgeBio Pharma, Inc.

Most recent Long-term assets (Other)of BBIO including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $18.0 $29.0 $33.0
2021 $31.0 $30.0 $49.8 $30.18 $33.03
2020 $23.93 $16.48 $17.25 $17.02 $23.93
2019 $26.29 $2.6 $26.29
2018 $1.09 $1.09
2017 $0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology